Evidence map›Paper›PMID 42807233›Full record

ArticleRSC advances2026

Design, synthesis, and preliminary anticancer evaluation of diphenylpropan-1-one derivatives:

Asim Najmi, Md Shamsher Alam, Waquar Ahsan, Khalid Zoghebi, Syam Mohan, Neelaveni Thangavel, Manal M E Taha, Mohammad Ashafaq, Md Afroz Bakht, Abdulkarim Meraya and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Asim NajmiDepartment of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University P. Box No. 114 Jazan Saudi Arabia anajmi@jazanu.edu.sa +966569762014.ORCID https://orcid.org/0000-0002-7529-5523
Md Shamsher AlamDepartment of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University P. Box No. 114 Jazan Saudi Arabia anajmi@jazanu.edu.sa +966569762014.
Waquar AhsanDepartment of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University P. Box No. 114 Jazan Saudi Arabia anajmi@jazanu.edu.sa +966569762014.ORCID https://orcid.org/0000-0002-5987-2933
Khalid ZoghebiDepartment of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University P. Box No. 114 Jazan Saudi Arabia anajmi@jazanu.edu.sa +966569762014.
Syam MohanSchool of Health Sciences, University of Petroleum and Energy Studies Dehradun Uttarakhand India.ORCID https://orcid.org/0000-0003-2077-1278
Neelaveni ThangavelRVS College of Pharmaceutical Sciences, Coimbatore, The Tamil Nadu Dr MGR Medical University Chennai Tamil Nadu India.
Manal M E TahaHealth Research Center, Jazan University P. Box No. 114 Jazan Saudi Arabia.
Mohammad AshafaqDepartment of Pharmacology and Toxicology, College of Pharmacy, Jazan University P. Box No. 114 Jazan Saudi Arabia.
Md Afroz BakhtDepartment of Chemistry, College of Science and Humanities, Prince Sattam Bin Abdulaziz University, Al-Kharj P.O. Box No. 83 Al-Kharj 11942 Saudi Arabia.
Abdulkarim MerayaDepartment of Pharmacy Practice, College of Pharmacy, Jazan University P. Box No. 114 Jazan Saudi Arabia.
Mohammed AlbrattyDepartment of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University P. Box No. 114 Jazan Saudi Arabia anajmi@jazanu.edu.sa +966569762014.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is a leading cause of cancer-associated mortality and morbidity worldwide, and there is a continued need for structurally diverse anticancer agents with improved properties. The present study reports a series of diphenylpropan-1-one (DPP) derivatives (4a-4i), rationally designed around a chalcone framework and synthesized

Identifiers

PMID42807233
PMCPMC13617378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.